Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Stephen M. Spaethe"'
Autor:
Jason Scott Sawyer, Michael J. Sofia, Peter W. Stengel, Steven A. Silbaugh, Stephen M. Spaethe, Sandra L. Cockerham, Alison M. Bendele, William T. Jackson, Larry L. Froelich
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 361:397-404
We examined the in vivo actions of LY293111 sodium (2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5-hydroxyphenoxy]pro poxy]phenoxy] benzoic acid sodium salt). Guinea pigs were used to evaluate the effect of this agent on (1) acute airway obstruction
Autor:
Philip Padrid, Phillip J. Cozzi, Stephen M. Spaethe, I. Maurice Ndukwu, Alan R. Leff, Richard W. Mitchell
Publikováno v:
British Journal of Pharmacology. 123:1198-1204
1 We determined the effect of cyclosporine A (CsA) treatment on mast cell degranulation and lung resistance (RL) in vivo, and tracheal smooth muscle (TSM) contraction ex vivo after antigen challenge in sensitized cats. We also determined the direct e
2-alkyl-4-ethyl-5-[6-methyl-6-(2H-tetrazol-5-yl)heptyloxy]phenol leukotriene B4 receptor antagonists
Autor:
Michael J. Sofia, David K. Herron, Katrina Ann Nelson, Philip Marder, Theodore Goodson, Jerome H. Fleisch, Larry L. Froelich, Carlos R. Roman, Stephen M. Spaethe
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 5:1995-2000
A series of 2-n-alkyl-4-ethyl-5-[6-methyl-6-(2H-tetrazol-5-yl)heptyloxy]phenols were prepared and shown to be potent leukotriene B4 (LTB4) receptor antagonists. They bound to the human neutrophil and guinea pig lung LTB4 receptors with high affinity.
Publikováno v:
Scopus-Elsevier
Guinea pigs mechanically hyperventilated with dry gas exhibit hyperpnea-induced bronchoconstriction (HIB) and hyperpnea-induced bronchovascular hyperpermeability (HIBVH). Tachykinins released from airway C-fiber neurons are the central mediators of g
Autor:
Jason Scott Sawyer, Floreancig Paul Edward, D. L. Jun. Saussy, Carlos R. Roman, Peter W. Stengel, Larry L. Froelich, Jerome H. Fleisch, Michael J. Sofia, Bach Nicholas J, Stephen Richard Baker, Sandra L. Cockerham, Stephen M. Spaethe, P. Marder, Elisabeth A. Schmittling, Baldwin Rf, J. A. Palkowitz, P. S. Borromeo, William T. Jackson, Steven A. Silbaugh
Publikováno v:
ChemInform. 27
Autor:
David K. Herron, Steven A. Silbaugh, Theodore Goodson, Carlos R. Roman, Jerome H. Fleisch, Stephen M. Spaethe, Sandra L. Cockerham, David L. Saussy, Peter W. Stengel
Publikováno v:
European Journal of Pharmacology. 223:57-64
The actions of LY255283, a leukotriene (LT) B4 receptor antagonist, were examined on guinea pig lung. LTB4 and LY255283 displaced [3H]LTB4 from its binding site on lung membranes with pKi values of 9.9 and 7.0, respectively. In the functional correla
Publikováno v:
Biochemical Pharmacology. 44:1609-1615
Previous findings revealed greater contractile responses of guinea pig lung pleural surface strips to antigen or A23187 challenge than denuded lung parenchymal strips (lung strip devoid of any pleura). Moreover, we have identified a high density of m
Publikováno v:
Journal of Immunological Methods. 144:257-263
The activity of eosinophil peroxidase (EPO) is commonly employed as a measure of eosinophil activation in biologic fluids. Determination of product formation by this enzyme by end-point measurement may be affected profoundly by substrate concentratio
Autor:
David P. Henry, Weihua L. Russell, Stephen M. Spaethe, Carlos R. Roman, Kerry G. Bemis, Jerome H. Fleisch, L E Rinkema, Winston Stanley Marshall
Publikováno v:
Journal of Pharmacy and Pharmacology. 42:620-625
LY171883, (1-[2-hydroxy-3-propyl-4-((4(1H-tetrazol-5-yl)butoxy)phenyl]ethanone), a leukotriene (LT) D4/E4 receptor antagonist, was assessed in comparison with two well known phosphodiesterase inhibitors, isobutylmethyl-xanthine (IBMX) and theophyllin
Autor:
Stephen M. Spaethe, E. L. van Alstyne, M. I. Mitchell, P. J. Barnes, David J. Evans, Brian J. O'Connor
Publikováno v:
Thorax. 51(12)
BACKGROUND: Leukotriene (LT) B4 is a potent neutrophil chemoattractant and also stimulates eosinophils in vitro, but its role in asthmatic inflammation is unknown. METHODS: The effect of the novel LTB4 receptor antagonist, LY293111, was examined usin